BRIEF-FDA accepts Spectral's expanded access protocol for toraymyxin

Mon Jun 27, 2016 8:16am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 27 (Reuters) - Spectral Medical Inc

* FDA accepts spectral's expanded access protocol for toraymyxin

* Says expanded access program, sometimes referred to as compassionate use, can now begin at certain of 29 U.S. hospitals

* Says similar program is planned for Canada, where there were 12 hospitals engaged in clinical trial Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)